Month: March 2026

Not for distribution to U.S. news wire services or dissemination in the United States VANCOUVER, BC, March 30, 2026 (GLOBE NEWSWIRE) — Company” or “Fobi“), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce that it has filed its annual audited financial statements for the fiscal year ended June 30, 2025, associated management discussion and analysis and related disclosures (together, the “2025 Annual Filings”), as well as its interim financial statements, MD&A, and accompanying CEO and CFO certifications for the periods ending September 30, 2025 and December 31, 2025, (together, the “2026 Interim Filings”). The 2025 Annual Filings and 2026 Interim Filings can be found under Fobi’s profile on www.sedarplus.ca.  With the filing of the 2025 Annual...

Display Interfaces as a Key Enabler of Physical AI, Advancing from Mass-Production to Real-World Deployment and Enabling New Smart Mobility Applications54″ Transparent Micro LED DisplayAUO has developed a 54 inch dessert and display showcase powered by Micro LED technology, featuring high brightness, a wide color gamut, and transparent display characteristics. The solution integrates AI enabled applications to present merchandise and brand information within a single view, allowing digital content to blend naturally into retail and smart living environments.HSINCHU, Taiwan, March 30, 2026 (GLOBE NEWSWIRE) — AI is taking shape through display interfaces, where people see and interact in real-world settings. Micro LED is a key display engine that helps bring AI into the physical world. At Touch Taiwan 2026, AUO, a...

LUXEMBOURG, March 30, 2026 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) filed today its 2025 Annual Report with the Luxembourg Stock Exchange, with the U.S. Securities and Exchange Commission (SEC) and with the other securities regulators of the markets where its securities are listed. The 2025 Annual Report, which may be downloaded from the Luxembourg Stock Exchange’s website at www.bourse.lu/regulated-information-oam and is also available on Tenaris’s website at ir.tenaris.com, includes the following:a consolidated management report containing the financial and non-financial information (or sustainability statement) required by applicable law; the consolidated financial statements as of and for the year ended 31st December 2025, the annual accounts as at 31st December 2025; and the management certifications...

SHANGHAI, and NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) — TH International Limited (“Tims China” (Nasdaq: THCH)), the exclusive operator of Tim Hortons coffee shops in China, plans to release its fourth quarter and full year 2025 results before market opening on Tuesday April 14, 2025, with a conference call to follow at 8:00 AM EST or 8:00 PM China Standard Time. The conference call will be webcast, and can be accessed on the company website at https://ir.timschina.com/events-presentations/presentations-webcasts. Participants are kindly encouraged to pre-register for the conference call, by using the link provided below. Pre-registration Link:https://register-conf.media-server.com/register/BIa8caf52166d74ea2961e15361ea8e13f ABOUT TH INTERNATIONAL LIMITED TH International Limited (Nasdaq: THCH) (“Tims China”) is the parent company...

NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) — Legato Merger Corp. III (NYSE American: LEGT U, LEGT, LEGT WS) (the “Company”) announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended November 30, 2025, which was filed on February 10, 2026 with the Securities and Exchange Commission, the audited financial statements contained an audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the Company’s ability to continue as a going concern. See further discussion in Note 1 to the Company’s financial statements included in the Company’s Annual Report on Form 10-K. This announcement is made pursuant to NYSE American LLC Company Guide Sections 401(h) and 610(b), which requires public announcement of the receipt of an audit opinion containing...

REYKJAVIK, ICELAND (March 30, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”) has filed its Annual Report 2025 on Form 20-F for the financial year 2025 with the U.S. Securities and Exchange Commission (SEC), incorporating by reference parts of the Alvotech Annual Report 2025. The report is available on the SEC’s website, www.sec.gov, as well as in the investor relations section of Alvotech’s website at https://investors.alvotech.com/financials. For further information, contact: MediaBenedikt StefanssonSarah MacLeodalvotech.media@alvotech.com InvestorsDr. Balaji V Prasad (US)Patrik Ling (SE)Benedikt Stefansson (IS)alvotech.ir@alvotech.com About AlvotechAlvotech is a biotechnology company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global...

REYKJAVIK, ICELAND (March 30, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”) has published its Annual Report for 2025. The report is available in the investor relations section of Alvotech’s website at: https://investors.alvotech.com/financials and is attached to this announcement in PDF and iXBRL formats. For further information, contact: MediaBenedikt StefanssonSarah MacLeodalvotech.media@alvotech.com InvestorsDr. Balaji V Prasad (US)Patrik Ling (SE)Benedikt Stefansson (IS)alvotech.ir@alvotech.com About AlvotechAlvotech is a biotechnology company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in biosimilars by delivering high-quality, cost-effective products and services, enabled by a fully integrated approach and broad...

REYKJAVIK, Iceland, March 30, 2026 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO) (the “Company”) has filed its Annual Report 2025 on Form 20-F for the financial year 2025 with the U.S. Securities and Exchange Commission (SEC), incorporating by reference parts of the Alvotech Annual Report 2025. The report is available on the SEC’s website, www.sec.gov, as well as in the investor relations section of Alvotech’s website at https://investors.alvotech.com/financials. For further information, contact: MediaBenedikt StefanssonSarah MacLeodalvotech.media@alvotech.com InvestorsDr. Balaji V Prasad (US)Patrik Ling (SE)Benedikt Stefansson (IS)alvotech.ir@alvotech.com About AlvotechAlvotech is a biotechnology company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech...

SCOTTSDALE, Ariz., March 30, 2026 (GLOBE NEWSWIRE) — Caliber (Nasdaq CWD), a diversified real estate and digital asset management platform, today announced that an institutional investor elected to convert approximately $15.9 million of perpetual convertible preferred equity into shares of the Company’s common stock. Under the original investment, Caliber issued 15,868 shares of Series B Preferred Stock at a purchase price of $1,000 per share, resulting in gross proceeds of $15,868,000. The holder has exercised its conversion right at a price of $250 per share, resulting in the issuance of 63,472 shares of common stock. The preferred equity carried no dividend and was perpetual in nature. The transaction removes approximately $15.9 million of preferred equity from the Company’s capital structure and replaces it with common equity....

BEIJING, March 30, 2026 (GLOBE NEWSWIRE) — JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter), the “Company” or “JD.com”), a leading supply chain-based technology and service provider, today announced that it proposes to offer CNY-denominated senior unsecured notes (the “Notes”) in offshore transactions outside the United States to non-U.S. persons in reliance on Regulation S under the United States Securities Act of 1933, as amended (the “Securities Act”), subject to market conditions and other factors (the “Notes Offering”). The principal amount, interest rates, maturity dates and other terms of the Notes will be determined at the time of pricing of the Notes Offering. The Company intends to use the net proceeds from the Notes Offering for general corporate purposes, including repayment of certain existing...